Larvol Delta - A-Study-of-225AcFPI2059-in-Adult-Participants-With-Solid-Tumours

actinium-225 zalsenertant tetraxetan (225Ac-FPI-2059) - 3B Pharma, AstraZeneca

http://clinicaltrials.gov/ct2/show/NCT05605522

Jan 28, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next